Member of Lyonbiopole
Holding with major stakes in the bioindustrial companies bioMérieux (diagnostics), Transgene (immunotherapy) and Mérieux NuriSciences (food safety and quality controls, nutrition) and also in the R&D company ABL, and in the invesment company Mérieux Développement
Strategic application domain: Human Medicine
Application market: Cardiology, Infectious Diseases, Oncology
Type of activity: Diagnostics, Therapeutics, Pharma or Biotech
Technologies: Vaccine, Others
Created on nov. 10th, 1897 - 15000 employees
Address
17 rue Bourgelat 69002 LYON
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.